Table 3.
Antimicrobial Susceptibility Profiles of 94 Uropathogenic CREC Isolates
| Antibiotics | %R | %I | %S | %R 95% CI |
|---|---|---|---|---|
| Ampicillin | 100 | 0 | 0 | 95.1–00 |
| Cefoperazone/Sulbactam | 81.4 | 13.5 | 5.1 | 68.7–89.9 |
| Ampicillin/Sulbactam | 98.8 | 1.2 | 0 | 92.7–99.9 |
| Piperacillin/Tazobactam | 51.1 | 26.6 | 22.3 | 40.6–61.5 |
| Ceftazidime | 98.9 | 0 | 1.1 | 93.3–99.9 |
| Ceftriaxone | 100 | 0 | 0 | 95.1–100 |
| Cefepime | 88.3 | 3.2 (SDD) | 8.5 | 79.6–93.7 |
| Cefoxitin | 98.3 | 1.7 | 0 | 89.7–99.9 |
| Aztreonam | 89.3 | 1.1 | 9.6 | 80.9–94.5 |
| Ertapenem | 100 | 0 | 0 | 95.1–100 |
| Imipenem | 36.2 | 2.1 | 61.7 | 26.7–46.8 |
| Meropenem | 47.5 | 0 | 52.5 | 34.5–60.8 |
| Amikacin | 10.7 | 1.1 | 88.2 | 5.6–19.4 |
| Gentamicin | 62.6 | 3.3 | 34.1 | 51.8–72.3 |
| Tobramycin | 43.8 | 29.2 | 27 | 33.4–54.7 |
| Ciprofloxacin | 95.7 | 0 | 4.3 | 88.8–98.6 |
| Levofloxacin | 93.6 | 4.3 | 2.1 | 86.1–97.4 |
| Trimethoprim/Sulfamethoxazole | 69.2 | 0 | 30.8 | 58.5–78.2 |
| Nitrofurantoin | 9 | 19.1 | 71.9 | 4.2–17.4 |
Abbreviations: SDD, susceptible-dose dependent; CI, confidence interval.